Rheumatology in and from Slovenia Ade AdebajoLuis R. Espinoza Editorial 05 October 2018 Pages: 271 - 271
The incidence rate and the early management of rheumatoid arthritis in Slovenia Rok JešeKatja Perdan-PirkmajerMatija Tomšič Original Article 02 August 2018 Pages: 273 - 278
The incidence of idiopathic inflammatory myopathies in the adult Slovenian population Jaka OstrovršnikAlojzija HočevarMatija Tomšič Original Article 02 August 2018 Pages: 279 - 283
The incidence of giant cell arteritis in Slovenia Nataša Potočnik PuceljAlojzija HočevarMatija Tomšič Original Article 30 July 2018 Pages: 285 - 290
Does leflunomide have a role in giant cell arteritis? An open-label study Alojzija HočevarRok JešeMatija Tomšič Original Article Open access 06 August 2018 Pages: 291 - 296
The persistence of golimumab compared to other tumour necrosis factor-α inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide longitudinal registry of patients treated with biologic disease-modifying antirheumatic drugs—BioRx.si Žiga RotarMatija Tomšičon behalf of the Slovenian Rheumatologists Original Article 15 October 2018 Pages: 297 - 305
Gene and miRNA expression in giant cell arteritis—a concise systematic review of significantly modified studies Tadeja KuretBlaž BurjaAlojzija Hočevar Review Article 01 August 2018 Pages: 307 - 316
Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients Blaž BurjaJulia FeichtingerAlojzija Hočevar Original Article Open access 24 August 2018 Pages: 317 - 329
Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis T. KuretK. LakotaA. Hočevar Original Article Open access 02 August 2018 Pages: 331 - 338
MicroRNA expression in the affected skin of adult patients with IgA vasculitis Alojzija HočevarMatija TomšičDamjan Glavač Original Article 06 August 2018 Pages: 339 - 345
Antiphospholipid antibodies in adult IgA vasculitis: observational study Alojzija HočevarŽiga RotarMatija Tomšič Brief Report 02 August 2018 Pages: 347 - 351
Autoantibodies against dsDNA measured with nonradioactive Farr assay—an alternative for routine laboratories K. LakotaT. ŠvecS. Čučnik Original Article 10 September 2018 Pages: 353 - 359
Clinically important neutralizing anti-drug antibodies detected with an in-house competitive ELISA Manca OgričPolona ŽigonSaša Čučnik Original Article 16 July 2018 Pages: 361 - 370
Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements Polona ŽigonAnuška PodovšovnikSaša Čučnik Original Article 11 August 2018 Pages: 371 - 378
Stroke and antiphospholipid syndrome—antiphospholipid antibodies are a risk factor for an ischemic cerebrovascular event Nataša GašperšičMarjan ZaletelAleš Ambrožič Original Article 07 August 2018 Pages: 379 - 384
Osteoporosis: a clinical and pharmacological update Maritza VidalRoss J. ThibodauxOsvaldo Daniel Messina Review Article 12 December 2018 Pages: 385 - 395
MicroRNA-146a expression and microRNA-146a rs2910164 polymorphism in Behcet’s disease patients W IbrahimB. R SakrH Ghonem Original Article 10 July 2018 Pages: 397 - 402
Detection of a novel mutation in NLRP3/CIAS1 gene in an Indian child with Neonatal-Onset Multisystem Inflammatory Disease (NOMID) Sona B. NairPallavi Pimpale ChavanRaju P. Khubchandani Original Article 31 July 2018 Pages: 403 - 406
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients Claudia FabianiAntonio VitaleLuca Cantarini Original Article 11 August 2018 Pages: 407 - 415
Endothelial dysfunction in patients with eosinophilic granulomatosis with polyangiitis Renata PacholczakStanisława Bazan-SochaJerzy Dropiński Original Article Open access 21 August 2018 Pages: 417 - 424
Efficacy and tolerance of anakinra in acute calcium pyrophosphate crystal arthritis: a retrospective study of 33 cases Marion ThomasMarine ForienSébastien Ottaviani Original Article 25 August 2018 Pages: 425 - 430
Association between the BANK1 rs3733197 polymorphism and polymyositis/dermatomyositis in a Chinese Han population Si ChenXiaoting WenYongzhe Li Original Article 25 August 2018 Pages: 431 - 436
Determination of the minimally important difference (MID) in multi-biomarker disease activity (MBDA) test scores: impact of diurnal and daily biomarker variation patterns on MBDA scores David ChernoffP. Scott EastmanJeffrey R. Curtis Original Article Open access 29 August 2018 Pages: 437 - 445
Association between primary Sjogren’s syndrome, arterial stiffness, and subclinical atherosclerosis: a systematic review and meta-analysis Wai Chung YongAnawin SanguankeoSikarin Upala Original Article 03 September 2018 Pages: 447 - 455
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study Serena FasanoDomenico Paolo Emanuele MargiottaGabriele Valentini Original Article 07 September 2018 Pages: 457 - 463
Correlation between magnetic resonance imaging (MRI) findings and the new bone formation factor Dkk-1 in patients with spondyloarthritis Zheng ZhaoGang WangFeng Huang Original Article Open access 11 September 2018 Pages: 465 - 475
Red blood cell distribution width as a potential predictor of survival of pulmonary arterial hypertension associated with primary Sjogren’s syndrome: a retrospective cohort study Min HuiJiuliang ZhaoXiaofeng Zeng Original Article Open access 14 September 2018 Pages: 477 - 485
Clinical role of albumin to globulin ratio in microscopic polyangiitis: a retrospective monocentric study Sung Soo AhnJuyoung YooSang-Won Lee Original Article 15 September 2018 Pages: 487 - 494
Serum interleukin-37 level and interleukin-37 gene polymorphism in patients with Behçet disease Selcan ÖzgüçlüTürker DumanÜmit Ölmez Original Article 18 September 2018 Pages: 495 - 502
Prevalence and frequency of self-perceived systemic features in people with joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type Cliffton ChanAnne KraheLeslie L. Nicholson Original Article 19 September 2018 Pages: 503 - 511
Gender differences in patients with fibromyalgia: a gait analysis Jose Heredia-JimenezEva Orantes-Gonzalez Original Article 21 September 2018 Pages: 513 - 522
Adverse drug events associated with 5mg versus 10mg Tofacitinib (Janus kinase inhibitor) twice daily for the treatment of autoimmune diseases: A systematic review and meta-analysis of randomized controlled trials Feng HuangZu-chun Luo Original Article 22 September 2018 Pages: 523 - 534
Active tuberculosis in patients with systemic lupus erythematosus from Southern China: a retrospective study Minxi LaoDongying ChenZhongping Zhan Original Article 23 September 2018 Pages: 535 - 543
Study of clinical utility of antibodies to phosphatidylserine/prothrombin complex in Asian-Indian patients with suspected APS Arvind GanapatiRuchika GoelDebashish Danda Original Article 26 September 2018 Pages: 545 - 553
Increasing incidence and shifting profile of idiopathic inflammatory rheumatic diseases in adults during this millennium Paula MuiluVappu RantalaihoKari Puolakka Original Article 26 September 2018 Pages: 555 - 562
Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind Christiaan ScottMercedes ChanRicardo Russo Original Article 28 September 2018 Pages: 563 - 575
On demand use of anakinra for attacks of familial Mediterranean fever (FMF) Hakan BabaogluOzkan VaranAbdurrahman Tufan Brief Report 30 July 2018 Pages: 577 - 581
Osteoarthritis: a call for research on central pain mechanism and personalized prevention strategies Jorge Hugo VillafañeKristin ValdesPedro Berjano Brief Report 21 August 2018 Pages: 583 - 584
Mycophenolate mofetil treatment with or without a calcineurin inhibitor in resistant inflammatory myopathy Hironari HanaokaHarunobu IidaKimito Kawahata Brief Report 14 September 2018 Pages: 585 - 590
Efficacy of new treatments for dactylitis of psoriatic arthritis: update of literature review Maxime SondagFrank VerhoevenDaniel Wendling Brief Report 16 October 2018 Pages: 591 - 596
The impact of obesity on SLE disease activity: findings from the Southern California Lupus Registry (SCOLR) Phildrich TehBishoy ZakharyVaneet K. Sandhu Brief Report 24 October 2018 Pages: 597 - 600
Severe necrotizing myositis associated with long term anti-neoplastic efficacy following nivolumab plus ipilimumab combination therapy Marie TauberRomain CohenArsène Mekinian Brief Report 19 November 2018 Pages: 601 - 602
Macrophage activation syndrome in a patient with axial spondyloarthritis on adalimumab Rahaf BakerJean W. LiewGordon Starkebaum Case Based Review 07 December 2018 Pages: 603 - 608
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease Silvia TamaniniMicaela FrediFranco Franceschini Letter to the Editor 05 November 2018 Pages: 609 - 610
It is time for an organised, scientific approach to the application of patient-reported outcome measures in clinical studies and trials Stephen P. McKenna Editorial 18 December 2018 Pages: 611 - 615
Correction to: the efficacy and safety of total glucosides of peony in the treatment of primary Sjögren’s syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial Xia LiuXiaomei LiGuochun Wang Correction 03 December 2018 Pages: 617 - 618